(Reuters) - Staff reviewers for the U.S. Food and Drug Administration said that a potential increased risk of cancer with drugs containing calcitonin salmon appears plausible. In briefing documents released on Friday, the reviewers said the risk raises concerns about the overall risk versus benefit of calcitonin products to treat osteoporosis in postmenopausal women. Calcitonin products include Novartis AG's Miacalcin injection and nasal spray and Unigene Laboratories Inc's nasal spray. Privately held Upsher Smith Laboratories Inc distributes Unigene's product in the United States. ...
via Health News Headlines - Yahoo! News CA Read More Here..
Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/03/fda-staff-say-calcitonin-salmon-cancer.html
No comments:
Post a Comment